Alkermes plc. (ALKS)
Sector: Healthcare
Industry: Pharmaceutical Preparations
Country: Ireland
Exchange: NASDAQ
Market cap: $7.28B
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Latest financial period: June 30, 2026
Filed with the SEC: July 28, 2026
Estimated earnings date: October 27, 2026
Profit #707 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROE/ROA | 53.3% | 67.2% | 77.7% | 83.5% |
Growth #1021 of 1484 companies
Payout #992 of 1484 companies
Safety #850 of 1484 companies
Price #1150 of 1484 companies
